Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration

PURPOSE: To evaluate the therapeutic potential and safety of intravitreal injections of bone marrow mononuclear fraction (BMMF) containing CD34(+) cells in patients with atrophic age-related macular degeneration (AMD). METHODS: Ten patients with atrophic AMD and best-corrected visual acuity (BCVA) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotrim, Carina Costa, Toscano, Luiza, Messias, André, Jorge, Rodrigo, Siqueira, Rubens Camargo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449098/
https://www.ncbi.nlm.nih.gov/pubmed/28579742
http://dx.doi.org/10.2147/OPTH.S133502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449098/
https://www.ncbi.nlm.nih.gov/pubmed/28579742
http://dx.doi.org/10.2147/OPTH.S133502

Ejemplares similares